insights_auto
Why is ORX down 2.74%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 0.85
arrow_downward
-2.74%(-0.024) 1D
Nov 16, 11:06:39 AM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
298.61M
Avg. vol.
777.72K
Volume
205.20K
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
298.61M
Avg. vol.
777.72K
Volume
205.20K
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Investing.com
·
1 hour ago
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
MarketWatch
·
53 minutes ago
Stock Market Today: Dow, S&P 500 and Nasdaq are set to fall as investors await Nvidia results and Anthropic's IPO this week: live updates
The Motley Fool
·
2 hours ago
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Billionaires.Africa
·
1 hour ago
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com